Ethopabate is a coccidiostat used in poultry. It is a synthetic anticoccidial agent formulated for inclusion in medicated feed or premixes to prevent and control coccidiosis caused by Eimeria species. Technically, ethopabate is supplied as a crystalline powder with low water solubility and greater solubility in common organic solvents, and it is compatible with typical premix carriers and feed processing conditions. The compound targets intracellular stages of the parasite life cycle, reducing oocyst shedding and lesion development when used at label-recommended inclusion rates. Typical technical grade material is supplied at high purity for formulation use and is handled and stored under cool, dry conditions to preserve assay and limit degradation.
Parent: Ethopabate
Parent: Ethopabate
Quality control for ethopabate focuses on assay, related substances, and limits for degradation and process-related impurities. A representative specification for technical material would require assay not less than 98.0 percent, individual related compounds typically limited to 0.3 to 0.5 percent each, unspecified impurities limited to 0.1 to 0.2 percent, and total related substances normally not to exceed 2.0 percent. Common related compounds monitored by HPLC include hydrolysis products, demethylated or de-esterified derivatives, and minor positional isomers or oxidative byproducts; residual solvents and heavy metals are controlled to pharmacopeial or regulatory limits. Analytical control is normally performed by validated HPLC methods with UV detection and supported by identity testing and stability monitoring.
Ethopabate is used to prevent and control coccidiosis in poultry flocks by reducing Eimeria infection pressure and oocyst shedding; it is administered via medicated feed or premix at product label inclusion rates and is intended as a prophylactic management tool in broiler, layer, and breeder programs.
